These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6900696)

  • 1. [Science of symptoms. Edema: systemic edema, ascites and clinical care--nephrotic syndrome and reinfusion of the ascitic fluid].
    Tamaki S; Terajima A; Yoshikawa T; Niizuma K
    Kango Gijutsu; 1980 Mar; 26(4):512-8. PubMed ID: 6900696
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the clearance of water and solutes caused by the reinfusion of ascitic ultrafiltrates in the chronic hepatorenal syndrome].
    Ruggieri G; Spinelli C; Valeri L; Romano M
    Recenti Prog Med; 1980 Mar; 68(3):293-301. PubMed ID: 7027378
    [No Abstract]   [Full Text] [Related]  

  • 3. [Measurement of the flow in venous reinfusion of ascitic fluid. Le Veen's peritoneojugular shunts].
    Paliard P; Partensky C; Mehier H
    Nouv Presse Med; 1980 Jan; 9(5):319-20. PubMed ID: 7355124
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of the Le Veen valve in the cure of ascites after the concentration-reinfusion treatment of the ascitic fluid].
    Torre GC; Binda GA; Testa R; Iachino G; Mattioli F
    Minerva Med; 1980 Mar; 71(9):627-30. PubMed ID: 7360398
    [No Abstract]   [Full Text] [Related]  

  • 5. [Protocol for reinfusion of ascites: 25 months of experience].
    Consolo F; Mileto G; Pellegrino E; Bellinghieri G; Ferraù O
    Minerva Nefrol; 1983; 30(1):51-2. PubMed ID: 6843886
    [No Abstract]   [Full Text] [Related]  

  • 6. Dialysis ascites-reinfusion of unmodified ascitic fluid.
    Jamil B; Jamal B [corrected to Jamil B]; Naqvi SA; Hussain R
    J Pak Med Assoc; 1994 Jul; 44(7):174-5. PubMed ID: 7933460
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cell-free and concentrated ascites reinfusion therapy(CART)].
    Yoshizawa A; Gyouda Y; Ishiguro T; Matsuzaki K; Yoshizawa T
    Gan To Kagaku Ryoho; 2012 Dec; 39 Suppl 1():33-5. PubMed ID: 23268893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of ascites with reinfusion of ascitic fluid concentrate].
    Narwan H; Demes M; Kovac A; Danninger F
    Bratisl Lek Listy; 2000; 101(5):306-9. PubMed ID: 11039198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative utility of sero ascites albumin gradient and ascitic fluid total protein for differential diagnosis of ascites.
    Das B; Acharya U; Purohit A
    Indian Pediatr; 1998 Jun; 35(6):542-5. PubMed ID: 10216650
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reinfusion ascites therapy: considerations after a year's experience].
    Russo GE; Caramiello MS; Vitaliano E; Fagiolo M; Pazienza M; Testorio M; Carmenini G; Sagliaschi G
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):79-83. PubMed ID: 7480964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of ascitic fluid in patients with nephrotic syndrome.
    Akalin HE; Fisher KA; Laleli Y; Caglar S
    Eur J Clin Invest; 1985 Jun; 15(3):138-40. PubMed ID: 3926507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of ascitic fluid in cardiac ascites.
    Christou L; Economou M; Economou G; Kolettis TM; Tsianos EV
    Scand J Gastroenterol; 2007 Sep; 42(9):1102-5. PubMed ID: 17710677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis.
    Jeffries MA; Stern MA; Gunaratnam NT; Fontana RJ
    Am J Gastroenterol; 1999 Oct; 94(10):2972-6. PubMed ID: 10520854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of intractable ascites at the terminal stage of ovarian carcinoma--reinfusion of the cell-free, concentrated ascitic fluid].
    Kitao M; Takahashi K; Iwaka O
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1668-71. PubMed ID: 6619618
    [No Abstract]   [Full Text] [Related]  

  • 15. An immunochemical study of the albumins of serum, urine, ascitic fluid and edema fluid in the nephrotic syndrome.
    GITLIN D; JANEWAY CA
    J Clin Invest; 1952 Feb; 31(2):223-30. PubMed ID: 14907904
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of ascites. A review.
    Watanabe A
    J Med; 1997; 28(1-2):21-30. PubMed ID: 9249607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascitic fluid concentrating device and concentrate reinfusion in treatment of refractory or massive ascites. Clinical trial in 40 patients.
    Huang MX; Jiang SJ; Xiao SD; Zeng MD; Qiu DK; Jiang FL; Wang YF
    Chin Med J (Engl); 1985 Jan; 98(1):7-12. PubMed ID: 3924502
    [No Abstract]   [Full Text] [Related]  

  • 18. Ascites is the primary cause of cancer antigen-125 (CA-125) elevation in systemic lupus erythematosus (SLE) patients with nephrotic syndrome.
    Basaran A; Zafer Tuncer S
    Med Hypotheses; 2007; 68(1):197-201. PubMed ID: 16979301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autogenous ascitic fluid infusion for cirrhotic ascites.
    Sivashanmugam R; Gopalan V; Radhakrishnan AR; Bhaskar N; Ramamurthy A; Prasad PV
    J Indian Med Assoc; 1982 Feb; 78(4):66-9. PubMed ID: 7108244
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of ascites by reinfusion of concentrated peritoneal fluid--review of 318 procedures in 210 patients.
    Lévy VG; Opolon P; Pauleau N; Caroli J
    Postgrad Med J; 1975 Aug; 51(598):564-6. PubMed ID: 1234342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.